West Duncan J, Williams Alan J
Cardiac Medicine, National Heart and Lung Institute, Imperial College London, Guy Scadding Building, London, UK.
Curr Pharm Des. 2007;13(24):2428-42. doi: 10.2174/138161207781368620.
Intracellular Ca(2+) release channels, such as inositol 1,4,5-trisphosphate receptors (IP(3)Rs) and ryanodine receptors (RyRs), facilitate the release of Ca(2+) from intracellular storage organelles in response to extracellular and intracellular stimuli. Consequently, these large, tetrameric proteins play a central role in Ca(2+) signalling and Ca(2+) homeostasis in virtually all cells. Recent data suggests that intracellular Ca(2+) release channels may also have an important pathophysiological function in certain disease states, including cardiac arrhythmias and heart failure. As a result, there has been much interest in the identification and characterization of novel, selective regulators of these channels. In this article, we review the wide array of pharmacological agents that interact directly with intracellular Ca(2+) release channels and describe the mechanisms underlying their ability to modify channel function.
细胞内钙离子释放通道,如肌醇1,4,5-三磷酸受体(IP₃Rs)和兰尼碱受体(RyRs),可响应细胞外和细胞内刺激,促进钙离子从细胞内储存细胞器中释放。因此,这些大型四聚体蛋白在几乎所有细胞的钙离子信号传导和钙离子稳态中发挥着核心作用。最近的数据表明,细胞内钙离子释放通道在某些疾病状态下,包括心律失常和心力衰竭,可能也具有重要的病理生理功能。因此,人们对鉴定和表征这些通道的新型选择性调节剂产生了浓厚兴趣。在本文中,我们综述了与细胞内钙离子释放通道直接相互作用的多种药理剂,并描述了它们改变通道功能能力的潜在机制。